ID30276A - Metode untuk mengobati gangguan-gangguan seksual - Google Patents

Metode untuk mengobati gangguan-gangguan seksual

Info

Publication number: ID30276A
Authority: ID; Indonesia
Prior art keywords: methods; sexual disorders; treating sexual; treating; disorders
Prior art date: 1999-01-06

Application number

IDW00200101412A

Other languages

English (en)

Inventor

Martin Durham Meglasson

Robert B Mccall

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-06

Filing date

1999-12-20

Publication date

2001-11-15

1999-12-20 Application filed by Upjohn Co filed Critical Upjohn Co

2001-11-15 Publication of ID30276A publication Critical patent/ID30276A/id

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IDW00200101412A 1999-01-06 1999-12-20 Metode untuk mengobati gangguan-gangguan seksual ID30276A (id)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US11484099P	1999-01-06	1999-01-06
US11505199P	1999-01-08	1999-01-08
US11592299P	1999-01-14	1999-01-14
US12054399P	1999-02-17	1999-02-17

Publications (1)

Publication Number	Publication Date
ID30276A true ID30276A (id)	2001-11-15

Family

ID=27493976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101412A ID30276A (id)	1999-01-06	1999-12-20	Metode untuk mengobati gangguan-gangguan seksual

Country Status (20)

Country	Link
US (9)	US6455564B1 (id)
EP (1)	EP1140092A2 (id)
JP (1)	JP2002534376A (id)
KR (1)	KR20010089779A (id)
CN (1)	CN1332628A (id)
AU (1)	AU782596B2 (id)
BR (1)	BR9916759A (id)
CA (1)	CA2350946A1 (id)
CO (1)	CO5150156A1 (id)
CZ (1)	CZ20012459A3 (id)
EA (2)	EA005412B1 (id)
HK (1)	HK1041812A1 (id)
HU (1)	HUP0105036A3 (id)
ID (1)	ID30276A (id)
IL (1)	IL144172A0 (id)
NZ (1)	NZ512820A (id)
PE (1)	PE20001374A1 (id)
SK (1)	SK7732001A3 (id)
TR (1)	TR200101895T2 (id)
WO (1)	WO2000040226A2 (id)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6455564B1 (en) *	1999-01-06	2002-09-24	Pharmacia & Upjohn Company	Method of treating sexual disturbances
KR20010089633A (ko) *	1999-02-05	2001-10-06	로렌스 티. 마이젠헬더	(5Ｒ)-(메틸아미노)-5,6-디히드로-4Ｈ-이미다조[4,5,1-ｉｊ]-퀴놀린-2(1Ｈ)-온의 제조 방법
EP1175204A4 (en) *	1999-05-04	2006-05-31	Aradigm Corp	AEROSOL FORMULATION AND ARTICLES FOR INCREASING LIBIDO IN WOMEN BY MOMENTARY TESTOSTERONE ADMINISTRATION
US7258850B2 (en)	1999-05-04	2007-08-21	Aradigm Corporation	Methods and compositions for treating erectile dysfunction
ES2238299T3 (es) *	1999-06-23	2005-09-01	Institut Pasteur	Peptidos para el tratamiento de trastornos interpersonales y conductuales alterados.
NZ531171A (en)	2000-04-21	2005-03-24	Upjohn Co	Cabergoline-type compounds for treating fibromyalgia and chronic fatigue syndrome
AR033520A1 (es) *	2000-04-27	2003-12-26	Upjohn Co	(5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona
AR031152A1 (es) *	2000-10-31	2003-09-10	Upjohn Co	Tratamientos nuevos para el sindrome de piernas inquietas
CA2435546A1 (en) *	2001-02-08	2002-08-15	Alice C. Martino	Rapid-onset medicament for the treatment of sexual dysfunction
US20030073609A1 (en)	2001-06-29	2003-04-17	Pinkerton Thomas C.	Enhanced pharmacokinetic profile of intradermally delivered substances
TW200307540A (en)	2002-04-25	2003-12-16	Wyeth Corp	[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
TWI312781B (en)	2002-04-25	2009-08-01		[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
TW200307682A (en)	2002-04-25	2003-12-16	Wyeth Corp	1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
SE0202365D0 (sv) *	2002-08-05	2002-08-05	Pharmacia Ab	New formulation and use thereof
US7037257B1 (en) *	2002-08-22	2006-05-02	Koenig J Frank	Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications
US20050043296A1 (en) *	2002-10-04	2005-02-24	Michael Hawley	Compositions and methods for treating sexual dysfunction
EP1546120A4 (en) *	2002-10-04	2006-11-22	Pharmacia Corp	PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE
BRPI0414149A (pt) *	2003-09-05	2006-10-31	Novartis Ag	composições compreendendo derivados de benzo(g)-quinolina e derivados de prostaglandina
GT200500317A (es)	2004-11-05	2006-10-27		Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
AR054849A1 (es)	2005-07-26	2007-07-18	Wyeth Corp	Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
WO2007016361A2 (en)	2005-07-29	2007-02-08	Concert Pharmaceuticals Inc.	Novel pharmaceutical compounds
JP2009507925A (ja) *	2005-09-13	2009-02-26	エランファーマインターナショナルリミテッド	ナノ粒子タダラフィル製剤
US7615075B2 (en) *	2005-11-04	2009-11-10	Rush University Medical Center	Plastic implant impregnated with a degradation protector
US20080004310A1 (en) *	2006-06-19	2008-01-03	Applied Pharmacy Services, Inc.	Lyophilized pharmaceutical composition
WO2017100324A1 (en) *	2015-12-10	2017-06-15	Repros Therapeutics Inc.	Combination therapy for treating female hypoactive sexual desire disorders
TWI795440B (zh)	2017-09-15	2023-03-11	美商佛瑪治療公司	作為ＣＢＰ／ｐ３００抑制劑之四氫─咪唑並喹啉化合物
CA3105099A1 (en)	2018-06-29	2020-01-02	Forma Therapeutics, Inc.	Inhibiting creb binding protein (cbp)
BR112021016921A2 (pt) *	2019-03-15	2021-11-03	Forma Therapeutics Inc	Inibição de proteína de ligação a elemento responsivo a amp cíclico (creb)
US11801243B2 (en)	2020-09-23	2023-10-31	Forma Therapeutics, Inc.	Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en)	2020-09-23	2023-10-24	Forma Therapeutics, Inc.	Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
EP4039746A1 (de)	2021-02-08	2022-08-10	Covestro Deutschland AG	Polycarbonat-polyester zusammensetzung, formmasse und formkörper mit guter schlagzähigkeit und hoher thermischer belastbarkeit

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4127118B1 (en)	1977-03-16	1995-12-19	Alvaro Latorre	Method of effecting and enhancing an erection
US4801587A (en)	1987-03-02	1989-01-31	Gene Voss	Impotence ointment
US4935514A (en) *	1989-06-06	1990-06-19	Ethyl Corporation	Thiation process
US5273975A (en) *	1989-06-09	1993-12-28	The Upjohn Company	Heterocyclic amines having central nervous system activity
WO1990015058A1 (en) *	1989-06-09	1990-12-13	The Upjohn Company	Heterocyclic amines having central nervous system activity
US5242391A (en)	1990-04-25	1993-09-07	Alza Corporation	Urethral insert for treatment of erectile dysfunction
US5250534A (en)	1990-06-20	1993-10-05	Pfizer Inc.	Pyrazolopyrimidinone antianginal agents
US5541211A (en)	1991-06-18	1996-07-30	Orion-Yhtyma Oy	Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9311920D0 (en)	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
CA2166700C (en) *	1993-07-27	2000-04-18	Arthur G. Romero	Heterocyclic amines having central nervous system activity
US5565466A (en) *	1993-08-13	1996-10-15	Zonagen, Inc.	Methods for modulating the human sexual response
AU703608B2 (en)	1994-04-22	1999-03-25	Pentech Pharmaceuticals, Inc.	Dosage forms and method for ameliorating male erectile dysfunction
EP0985671B1 (en) *	1996-05-31	2003-04-02	Mochida Pharmaceutical Co., Ltd.	PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
US6455564B1 (en) *	1999-01-06	2002-09-24	Pharmacia & Upjohn Company	Method of treating sexual disturbances

1999
- 1999-12-17 US US09/465,668 patent/US6455564B1/en not_active Expired - Fee Related
- 1999-12-20 CN CN99815155A patent/CN1332628A/zh active Pending
- 1999-12-20 JP JP2000591983A patent/JP2002534376A/ja active Pending
- 1999-12-20 EA EA200100750A patent/EA005412B1/ru not_active IP Right Cessation
- 1999-12-20 EP EP99967142A patent/EP1140092A2/en not_active Withdrawn
- 1999-12-20 AU AU23482/00A patent/AU782596B2/en not_active Ceased
- 1999-12-20 CA CA002350946A patent/CA2350946A1/en not_active Abandoned
- 1999-12-20 BR BR9916759-0A patent/BR9916759A/pt not_active IP Right Cessation
- 1999-12-20 EA EA200401256A patent/EA200401256A1/ru unknown
- 1999-12-20 HU HU0105036A patent/HUP0105036A3/hu unknown
- 1999-12-20 SK SK773-2001A patent/SK7732001A3/sk unknown
- 1999-12-20 CZ CZ20012459A patent/CZ20012459A3/cs unknown
- 1999-12-20 IL IL14417299A patent/IL144172A0/xx unknown
- 1999-12-20 NZ NZ512820A patent/NZ512820A/xx unknown
- 1999-12-20 WO PCT/US1999/027951 patent/WO2000040226A2/en not_active Application Discontinuation
- 1999-12-20 TR TR2001/01895T patent/TR200101895T2/xx unknown
- 1999-12-20 KR KR1020017008566A patent/KR20010089779A/ko not_active Application Discontinuation
- 1999-12-20 ID IDW00200101412A patent/ID30276A/id unknown
- 1999-12-28 PE PE1999001327A patent/PE20001374A1/es not_active Application Discontinuation
- 1999-12-30 CO CO99081563A patent/CO5150156A1/es unknown
2002
- 2002-02-19 US US10/078,611 patent/US6921771B2/en not_active Expired - Fee Related
- 2002-05-04 HK HK02103392.6A patent/HK1041812A1/zh unknown
- 2002-07-30 US US10/208,353 patent/US6809112B2/en not_active Expired - Fee Related
- 2002-07-30 US US10/208,084 patent/US6890945B2/en not_active Expired - Fee Related
- 2002-07-30 US US10/208,644 patent/US6903127B2/en not_active Expired - Fee Related
2004
- 2004-05-14 US US10/846,132 patent/US20040214823A1/en not_active Abandoned
- 2004-05-24 US US10/852,646 patent/US20040214826A1/en not_active Abandoned
- 2004-05-24 US US10/852,352 patent/US20040214825A1/en not_active Abandoned
- 2004-05-24 US US10/852,330 patent/US20040214824A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20030013710A1 (en)	2003-01-16
EA005412B1 (ru)	2005-02-24
PE20001374A1 (es)	2000-11-19
SK7732001A3 (en)	2001-12-03
AU782596B2 (en)	2005-08-11
US20040214826A1 (en)	2004-10-28
JP2002534376A (ja)	2002-10-15
US20040214825A1 (en)	2004-10-28
EP1140092A2 (en)	2001-10-10
HUP0105036A2 (hu)	2002-05-29
US20020107247A1 (en)	2002-08-08
NZ512820A (en)	2002-12-20
US20040214823A1 (en)	2004-10-28
KR20010089779A (ko)	2001-10-08
CA2350946A1 (en)	2000-07-13
TR200101895T2 (tr)	2001-12-21
BR9916759A (pt)	2001-09-25
IL144172A0 (en)	2002-05-23
EA200401256A1 (ru)	2005-12-29
US6921771B2 (en)	2005-07-26
CZ20012459A3 (cs)	2002-01-16
US6809112B2 (en)	2004-10-26
AU2348200A (en)	2000-07-24
CO5150156A1 (es)	2002-04-29
US6455564B1 (en)	2002-09-24
US20040214824A1 (en)	2004-10-28
US6903127B2 (en)	2005-06-07
US20030004152A1 (en)	2003-01-02
HK1041812A1 (zh)	2002-07-26
WO2000040226A3 (en)	2001-02-01
US20020198187A1 (en)	2002-12-26
US6890945B2 (en)	2005-05-10
HUP0105036A3 (en)	2002-10-28
EA200100750A1 (ru)	2001-12-24
WO2000040226A2 (en)	2000-07-13
CN1332628A (zh)	2002-01-23

Publication	Publication Date	Title
ID30276A (id)	2001-11-15	Metode untuk mengobati gangguan-gangguan seksual
NO20001870L (no)	2000-10-16	Ny fremgangsmÕte for behandling
NO993051L (no)	1999-12-23	Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20004688D0 (no)	2000-09-19	Terapi ved østrogenassosierte lidelser
DE69924365D1 (de)	2005-04-28	Massagegerät
DE60017514D1 (de)	2005-02-24	Laserbehandlungsgerät
HK1142833A1 (en)	2010-12-17	Methods for the treatment of cellular proliferative disorders
EP1328186A4 (en)	2006-03-22	METHODS OF TREATING VARIOUS EYES DISEASES
ID30339A (id)	2001-11-22	Metode pengobatan baru
PT1206436E (pt)	2004-12-31	Retinoides para o tratamento de enfisema
DE60023454D1 (de)	2005-12-01	Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
PL368556A1 (en)	2005-04-04	Methods for treating or preventing skin disorders using cd2-binding agents
HK1039555A1 (en)	2002-05-03	Device for targeted topical treatment of disease
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
NO20032789L (no)	2003-08-18	Apparat for lipolyse for estetisk behandling
NO20013337L (no)	2001-08-17	Ny behandling
NO20013596D0 (no)	2001-07-20	Slambehandling
IL155769A0 (en)	2003-12-23	Method for the treatment of inflammation
DE60037935D1 (de)	2008-03-20	Kontinuierliches behandlungssystem
PT1051172E (pt)	2005-03-31	Metodo para tratamento da dpco
ES1044983Y (es)	2000-12-16	Aparato de termoestimulacion para tratamientos terapeuticos.
ID30458A (id)	2001-12-06	Osanetan dalam pengobatan gangguan jiwa
PT1200447E (pt)	2004-02-27	Oxazinocarbazoles para o tratamento de doencas do snc
NO20006383D0 (no)	2000-12-14	Fremgangsmåte for behandling
IS6020A (is)	2001-07-23	S-nítrósóþíól til meðferðar við blóðrásartruflunum